BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.06B |
| 2 |
Tesla
TSLA
|
+$468M |
| 3 |
AbbVie
ABBV
|
+$312M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$266M |
| 5 |
Abbott
ABT
|
+$254M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$609M |
| 2 |
Apple
AAPL
|
+$577M |
| 3 |
Visa
V
|
+$476M |
| 4 |
iShares MSCI ACWI ETF
ACWI
|
+$434M |
| 5 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$239M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.37% |
| 2 | Financials | 8.23% |
| 3 | Consumer Discretionary | 6.83% |
| 4 | Healthcare | 6.12% |
| 5 | Communication Services | 4.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3026
Republic Bancorp
RBCAA
$1.93B
| $66.4K | ﹤0.01% |
1,439
-3,283
| -70% | -$150K |
|
3027
Waterstone Financial
WSBF
$381M
| $66.3K | ﹤0.01% |
3,372
-6,686
| -66% | -$134K |
|
|
NESR
3028
National Energy Services Reunited Corp
NESR
$3.61B
| $66.3K | ﹤0.01% |
4,652
-5,386
| -54% | -$72.4K |
|
3029
Tidewater
TDW
$4.54B
| $66.3K | ﹤0.01% |
5,499
-16,399
| -75% | -$218K |
|
3030
Atossa Therapeutics
ATOS
$24.6M
| $66.3K | ﹤0.01% |
+699
| New | +$37K |
|
3031
Grupo Aeroportuario del Pacifico
PAC
$12.5B
| $66K | ﹤0.01% |
617
| – | – |
|
|
FLIC
3032
DELISTED
First of Long Island Corp
FLIC
| $65.8K | ﹤0.01% |
3,099
-7,454
| -71% | -$163K |
|
3033
Kearny Financial
KRNY
$607M
| $65.6K | ﹤0.01% |
5,493
-22,011
| -80% | -$278K |
|
3034
Bank First Corp
BFC
$1.75B
| $65.6K | ﹤0.01% |
940
-76
| -7% | -$5.43K |
|
|
BFX
3035
DELISTED
BowFlex Inc.
BFX
| $65.5K | ﹤0.01% |
3,887
-21,305
| -85% | -$359K |
|
3036
Mercantile Bank Corp
MBWM
$1.07B
| $65.4K | ﹤0.01% |
2,167
-5,145
| -70% | -$164K |
|
3037
Bar Harbor Bankshares
BHB
$681M
| $65.4K | ﹤0.01% |
2,285
-4,967
| -68% | -$146K |
|
|
NGM
3038
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $65.4K | ﹤0.01% |
3,315
-119
| -3% | -$2.79K |
|
|
KBAL
3039
DELISTED
Kimball International
KBAL
| $65.1K | ﹤0.01% |
4,953
-11,750
| -70% | -$160K |
|
|
STEL
3040
DELISTED
Stellar Bancorp
STEL
| $65.1K | ﹤0.01% |
2,382
-5,727
| -71% | -$172K |
|
3041
Merchants Bancorp
MBIN
$2.55B
| $64.9K | ﹤0.01% |
2,481
-4,077
| -62% | -$113K |
|
3042
MBIA
MBI
$257M
| $64.2K | ﹤0.01% |
5,833
-17,113
| -75% | -$170K |
|
3043
Viking Therapeutics
VKTX
$3.89B
| $64.1K | ﹤0.01% |
10,703
-23,551
| -69% | -$140K |
|
3044
PJT Partners
PJT
$4.39B
| $64.1K | ﹤0.01% |
898
-2,569
| -74% | -$183K |
|
3045
Prothena Corp
PRTA
$472M
| $64.1K | ﹤0.01% |
1,246
-16,350
| -93% | -$510K |
|
|
OLP
3046
One Liberty Properties
OLP
$531M
| $63.9K | ﹤0.01% |
2,251
-5,117
| -69% | -$132K |
|
3047
International Seaways
INSW
$4.68B
| $63.8K | ﹤0.01% |
3,326
-8,698
| -72% | -$169K |
|
3048
Financial Institutions
FISI
$828M
| $63.6K | ﹤0.01% |
2,119
-4,741
| -69% | -$148K |
|
3049
W&T Offshore
WTI
$548M
| $63.5K | ﹤0.01% |
13,086
-31,458
| -71% | -$121K |
|
|
CDMO
3050
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $62.9K | ﹤0.01% |
2,453
-6,025
| -71% | -$129K |
|
Similar funds
BNP Paribas Financial Markets's Q2 2021 Portfolio in Review
As of Q2 2021, BNP Paribas Financial Markets held 4,172 positions worth $75.6B, up 11% from $68.3B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
BNP Paribas Financial Markets's Q2 2021 filing shows 175 new, 1,539 increased, 1,937 reduced and 124 closed positions. Its largest new stake was FlexShares Global Upstream Natural Resources Index Fund: 708,078 shares worth $27.1M. The largest sale was Invesco QQQ Trust, an estimated $609M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 13% a quarter earlier, followed by Financials and Consumer Discretionary.
- BNP Paribas Financial Markets's largest Q2 2021 buy was FlexShares Global Upstream Natural Resources Index Fund: 708,078 shares worth $27.1M.
- BNP Paribas Financial Markets added most to State Street SPDR S&P 500 ETF Trust in Q2 2021, an estimated $1.06B increase.
- BNP Paribas Financial Markets's biggest Q2 2021 reduction was Invesco QQQ Trust, cutting an estimated $609M.
- BNP Paribas Financial Markets fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $123M.
- BNP Paribas Financial Markets's ten largest holdings make up 13% of its $75.6B portfolio in Q2 2021.
- BNP Paribas Financial Markets opened 175 new positions and closed 124 in Q2 2021.
- BNP Paribas Financial Markets's portfolio value rose 11% quarter-over-quarter to $75.6B.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2021, filed 10 Aug 2021.